GCP
DTIL icon

GSA Capital Partners’s Precision BioSciences DTIL Stock Holding History

GSA Capital Partners’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,767
Closed -$161K – 1822
2025
Q4 		$161K Buy
38,767
+21,045
+119% +$119K 0.01% 1462
2025
Q3 		$98K Buy
+17,722
New +$84.9K 0.01% 1526
2024
Q2 		– Sell
-10,067
Closed -$137K – 1719
2024
Q1 		$137K Buy
+10,067
New +$123K 0.01% 1462
2023
Q3 		– Sell
-15,666
Closed -$247K – 1589
2023
Q2 		$247K Sell
15,666
-767
-5% -$17.5K 0.02% 1153
2023
Q1 		$372K Buy
16,433
+7,042
+75% +$232K 0.04% 896
2022
Q4 		$335K Sell
9,391
-1,075
-10% -$42.5K 0.04% 862
2022
Q3 		$408K Buy
10,466
+5,726
+121% +$272K 0.05% 724
2022
Q2 		$227K Buy
4,740
+987
+26% +$57.9K 0.03% 1007
2022
Q1 		$347K Buy
3,753
+2,038
+119% +$277K 0.05% 794
2021
Q4 		$381K Sell
1,715
-133
-7% -$37.1K 0.05% 772
2021
Q3 		$640K Buy
+1,848
New +$626K 0.07% 543
2020
Q4 		– Sell
-4,954
Closed -$916K – 1287
2020
Q3 		$916K Buy
4,954
+4,284
+639% +$852K 0.15% 121
2020
Q2 		$168K Buy
+670
New +$147K 0.09% 389

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

GSA Capital Partners's DTIL Position: Q1 2026 in Review

GSA Capital Partners sold out of Precision BioSciences (DTIL) in Q1 2026, closing a stake of 38,767 shares — an estimated $161K sold.

GSA Capital Partners first reported a position in DTIL in Q2 2020 and held it in 13 quarters. The position peaked at $916K in Q3 2020. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • GSA Capital Partners reported no remaining Precision BioSciences position as of Q1 2026 after selling out during the quarter.
  • GSA Capital Partners sold 38,767 Precision BioSciences shares in Q1 2026, an estimated $161K.
  • GSA Capital Partners first reported a position in Precision BioSciences in Q2 2020 and held it in 13 quarters.
  • GSA Capital Partners's Precision BioSciences position peaked at $916K in Q3 2020.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.